Intersect ENT (Menlo Park, California), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, reported initial results from RESOLVE, a clinical study of the company's investigational steroid eluting implant designed to treat patients with recurrent sinus obstruction in the office setting. Results were presented at the annual American Rhinologic Society (Warwick, New York) meeting in Orlando. Read More
